CNSP

CNS Pharmaceuticals

• Benzinga·03/18 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• TipRanks·03/11 13:02

  CNS Pharmaceuticals Unveils Strategic Pivot to Broader Oncology

• TipRanks·03/11 12:52

  CNS Pharmaceuticals launches new corporate growth strategy

• Benzinga·03/11 12:42

  CNS Pharmaceuticals Launches Global Search For Neurology And Oncology Assets, Shifts Focus From Glioblastoma

• Reuters·03/11 12:35

  CNS Pharmaceuticals to Pursue Acquisition and In-Licensing of Neurology and Oncology Assets, While Exploring Out-Licensing of Berubicin and TPI 287 to Build a New Pipeline

• TipRanks·03/06 13:15

  CNS Pharmaceuticals (CNSP) Receives a Buy from Maxim Group

• Reuters·03/04 22:02

  CNS Pharmaceuticals Files Initial Beneficial Ownership Statement for CTO Eric Faulkner

• Reuters·03/04 22:00

  CNS Pharmaceuticals Files Initial Beneficial Ownership Statement for CFO Steve O’Loughlin

• TipRanks·03/02 23:12

  CNS Pharmaceuticals Appoints New Chief Medical Officer

• TipRanks·03/02 13:42

  CNS Pharmaceuticals appoints Lynne Kelley as CMO

• Reuters·03/02 13:25

  CNS Pharmaceuticals names Lynne Kelley chief medical officer

• TipRanks·02/17 13:58

  CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO

• TipRanks·02/17 13:45

  CNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO

• Benzinga·02/17 13:42

  CNS Pharmaceuticals Appoints Steve O'Loughlin CFO, Effective March 2, Succeeding Christopher Downs

• Reuters·02/17 13:37

  CNS PHARMACEUTICALS INC - APPOINTS STEVE O'LOUGHLIN AS CFO, EFFECTIVE MARCH 2 - SEC FILING